檢索結果 - Bob T. Li

Refine Results
  1. 1
    Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice

    Treatment and Prevention of Bone Metastases from Breast Cancer: A Comprehensive Review of Evidence for Clinical Practice 由 Bob T. Li, Matthew H. Wong, Nick Pavlakis

    出版 2014
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of <em>NTRK</em>, <em>ROS1</em>, and <em>ALK</em> fusion-positive solid tumors

    Entrectinib: an orally available, selective tyrosine kinase inhibitor for the treatment of <em>NTRK</em>, <em>ROS1</em>, and <em>ALK</em> fusion... 由 Dazhi Liu, Michael Offin, Stephen Harnicar, Bob T. Li, Alexander Drilon

    出版 2018
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers

    Outcomes of chemotherapies and HER2 directed therapies in advanced HER2-mutant lung cancers 由 Juliana Eng, Meier Hsu, Jamie E. Chaft, Mark G. Kris, Maria E. Arcila, Bob T. Li

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer

    Epidermal growth factor receptor (EGFR) inhibitors for metastatic colorectal cancer 由 David Chan, Eva Segelov, Ivon Harliwong, Annabel Smith, Rebecca Herbertson, Bob T. Li, Niall C. Tebbutt, Timothy Price, Nick Pavlakis

    出版 2017
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  5. 5
    Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies

    Toxicities of the anti-PD-1 and anti-PD-L1 immune checkpoint antibodies 由 Jarushka Naidoo, David B. Page, Bob T. Li, Louise C. Connell, Katja Schindler, Mario E. Lacouture, Michael A. Postow, Jedd D. Wolchok

    出版 2015
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  6. 6
    A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers

    A prospective study of total plasma cell-free DNA as a predictive biomarker for response to systemic therapy in patients with advanced non-small-cell lung cancers 由 Bob T. Li, Alexander Drilon, Melissa L. Johnson, Meier Hsu, Camelia S. Sima, C. McGinn, Hirofumi Sugita, Mark G. Kris, Christopher G. Azzoli

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers

    HER2 Amplification and HER2 Mutation Are Distinct Molecular Targets in Lung Cancers 由 Bob T. Li, Dara S. Ross, Dara L. Aisner, Jamie E. Chaft, Meier Hsu, Severine Kako, Mark G. Kris, Marileila Varella‐Garcia, Maria E. Arcila

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer

    Factors influencing the utilization of prophylactic cranial irradiation in patients with limited-stage small cell lung cancer 由 Benjamin H. Lok, Jennifer Ma, Amanda Foster, Carmen A. Perez, Weiji Shi, Zhigang Zhang, Bob T. Li, Charles M. Rudin, Andreas Rimner, Abraham J. Wu

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases

    Phase I Study of Intermittent High-Dose Lapatinib Alternating with Capecitabine for HER2-Positive Breast Cancer Patients with Central Nervous System Metastases 由 Aki Morikawa, Elisa de Stanchina, Elena Pentsova, Margaret Kemeny, Bob T. Li, Kendrick Tang, Sujata Patil, Martin Fleisher, Catherine Van Poznak, Larry Norton, Andrew D. Seidman

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumors

    Targeting HER2 aberrations as actionable drivers in lung cancers: phase II trial of the pan-HER tyrosine kinase inhibitor dacomitinib in patients with HER2-mutant or amplified tumo... 由 Mark G. Kris, D. Ross Camidge, Giuseppe Giaccone, Toyoaki Hida, Bob T. Li, Joseph O’Connell, Ian W. Taylor, H. Zhang, Maria E. Arcila, Zelanna Goldberg, Pasi A. Jänne

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib

    Clinical validation of Guardant360 CDx as a blood-based companion diagnostic for sotorasib 由 Joshua Bauml, Bob T. Li, Vamsidhar Velcheti, Ramaswamy Govindan, Alessandra Curioni‐Fontecedro, Christophe Dooms, Toshiaki Takahashi, Andrew W. Duda, Justin I. Odegaard, Fernando Cruz‐Guilloty, Liming Jin, Ying Zhang, Abraham Anderson, Ferdinandos Skoulidis

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management

    Multidisciplinary clinical guidance on trastuzumab deruxtecan (T-DXd)–related interstitial lung disease/pneumonitis—Focus on proactive monitoring, diagnosis, and management 由 Sandra M. Swain, Mizuki Nishino, Lisa Lancaster, Bob T. Li, Andrew G. Nicholson, Brian J. Bartholmai, Jarushka Naidoo, Eva Schumacher-Wulf, Kohei Shitara, Junji Tsurutani, Pierfranco Conté, Terufumi Kato, Fabrice André, Charles A. Powell

    出版 2022
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced <i>KRAS G12C</i>-Mutant Non–Small Cell Lung Cancer

    Clinical and Genomic Features of Response and Toxicity to Sotorasib in a Real-World Cohort of Patients With Advanced <i>KRAS G12C</i>-Mutant Non–Small Cell Lung Cancer 由 Rohit Thummalapalli, Ezra Bernstein, Benjamin Herzberg, Bob T. Li, Afsheen Iqbal, Isabel R. Preeshagul, Fernando C. Santini, Juliana Eng, Marc Ladanyi, Soo‐Ryum Yang, Ronglai Shen, Piro Lito, Gregory J. Riely, Joshua K. Sabari, Kathryn C. Arbour

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Screening for <i><scp>ROS</scp>1</i> gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with <scp>FISH</scp> confirmation is an effective method to identify this rare target

    Screening for <i><scp>ROS</scp>1</i> gene rearrangements in non‐small‐cell lung cancers using immunohistochemistry with <scp>FISH</scp> confirmation is an effective method to ident... 由 Christina Selinger, Bob T. Li, Nick Pavlakis, Matthew Links, Anthony J. Gill, Adrian Lee, Stephen Clarke, Trần Nam Thắng, Trina Lum, Po Yee Yip, Lisa G. Horvath, Bing Yu, Maija Kohonen‐Corish, Sandra O’Toole, Wendy A. Cooper

    出版 2016
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers

    Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with <i>EGFR</i>-Mutant Lung Cancers 由 Michael Offin, Hira Rizvi, Megan Tenet, Ai Ni, Francisco Sánchez-Vega, Bob T. Li, Alexander Drilon, Mark G. Kris, Charles M. Rudin, Nikolaus Schultz, Maria E. Arcila, Marc Ladanyi, Gregory J. Riely, Helena A. Yu, Matthew D. Hellmann

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors

    Targeting HER2 with Trastuzumab Deruxtecan: A Dose-Expansion, Phase I Study in Multiple Advanced Solid Tumors 由 Junji Tsurutani, Hiroji Iwata, Ian E. Krop, Pasi A. Jänne, Toshihiko Doi, Shunji Takahashi, Haeseong Park, Charles H. Redfern, Kenji Tamura, Trisha M. Wise‐Draper, Kaku Saito, Masahiro Sugihara, Jasmeet Singh, Takahiro Jikoh, Gilles Gallant, Bob T. Li

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    EGFR-directed antibodies promote HER2 ADC internalization and efficacy

    EGFR-directed antibodies promote HER2 ADC internalization and efficacy 由 Avantika Gupta, Flavia Michelini, Hong Shao, Celine Yeh, Joshua Z. Drago, Dazhi Liu, Eric Rosiek, Yevgeniy Romin, Negin Ghafourian, Sheeno Thyparambil, Sandra Misale, Wungki Park, Elisa de Stanchina, Yelena Y. Janjigian, Rona Yaeger, Bob T. Li, Sarat Chandarlapaty

    出版 2024
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance

    Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance 由 Helena A. Yu, Ken Suzawa, Emmet Jordan, Ahmet Zehir, Ai Ni, Hyunjae R. Kim, Mark G. Kris, Matthew D. Hellmann, Bob T. Li, Romel Somwar, David B. Solit, Michael F. Berger, Maria E. Arcila, Gregory J. Riely, Marc Ladanyi

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations

    Circulating Tumor DNA Profiling in Small-Cell Lung Cancer Identifies Potentially Targetable Alterations 由 Siddhartha Devarakonda, Sumithra Sankararaman, Brett H. Herzog, Kathryn A. Gold, Saiama N. Waqar, Jeffrey P. Ward, Victoria M. Raymond, Richard B. Lanman, Aadel A. Chaudhuri, Taofeek K. Owonikoko, Bob T. Li, John T. Poirier, Charles M. Rudin, Ramaswamy Govindan, Daniel Morgensztern

    出版 2019
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis

    Genomic analysis and clinical correlations of non-small cell lung cancer brain metastasis 由 Anna Skakodub, Henry Walch, Kathryn R. Tringale, Jordan Eichholz, Brandon S. Imber, Harish N. Vasudevan, Bob T. Li, Nelson S. Moss, Kenny Yu, Boris Mueller, Simon N. Powell, Pedram Razavi, Helena A. Yu, Jorge S. Reis‐Filho, Daniel R. Gomez, Nikolaus Schultz, Luke Pike

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: